(Q35081118)

6 August 2017

1 reference

title

Positron emission tomography in cancer research and treatment (English)

1 reference

positron emission tomography

6 August 2017

main subject

1 reference

1

Mark Mandelkern

1 reference

6 August 2017

Jonathan Raines

2

1 reference

6 August 2017

publication date

1 December 2002

1 reference

Technology in Cancer Research and Treatment

6 August 2017

published in

1 reference

6 August 2017

volume

1

1 reference

6 August 2017

issue

6

1 reference

6 August 2017

page(s)

423-439

1 reference

Transformation of rat fibroblasts by FSV rapidly increases glucose transporter gene transcription.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

Trafficking of glucose transporters--signals and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

FDG positron emission tomography in head and neck cancer: pitfall or pathology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

Positron emission tomography in prostate and renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

Advantage of delayed whole-body FDG-PET imaging for tumour detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

Positron emission tomography imaging in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

Positron emission tomography in patients with glioma. A predictor of prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

Positron emission tomography with f18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

Fluorodeoxyglucose positron emission tomography (FDG-PET) in the differential diagnosis of pancreatic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

Asymptomatic adnexal masses: correlation of FDG PET and histopathologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

Positron emission tomography with (18)F-fluorodeoxyglucose of uterine sarcoma: a comparison with magnetic resonance imaging and power Doppler imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

Usefulness of (18)F-FDG PET in the post-therapy surveillance of endometrial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

FDG PET for evaluating the change of glucose metabolism in prostate cancer after androgen ablation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

FDG-PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

Initial results in the assessment of multiple myeloma using 18F-FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

Functional imaging of malignant paragangliomas and carcinoid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

Staging of regional nodes in AJCC stage I and II melanoma: 18FDG PET imaging versus sentinel node detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

Fluorinated amino acids for tumour imaging with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

Imaging proliferation in vivo with [F-18]FLT and positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

Radiolabeled peptides in diagnosis and tumor imaging: clinical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

PET imaging of transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer: Potential impact on treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100603

10.1177/153303460200100603

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference